Neuraly Case Study: Helping a revolutionary clinical-stage biotechnology company become GCP compliant - Arkivum

Neuraly Case Study: Helping a revolutionary clinical-stage biotechnology company become GCP compliant

Neuraly Case Study: Helping a revolutionary clinical-stage biotechnology company become GCP compliant

You can access the full Neuraly case study here.

With two clinical studies in Phase II and three more in pre-clinical stages, Neuraly – a clinical-stage biotechnology company –  sought to outsource the archival of the electronic trial master file (eTMF) to ensure that they were compliant with the requirements that have been set out by Good Clinical Practice (GCP).

Some of the challenges Neuraly faced were:

  • Safeguarding the data to ensure that it is not lost or corrupted.
  • Archiving the data in such a way that it could be easily found if required.
  • Preserving the data so that the information could be read and used.

 

As part of the implementation and integration of the archiving and preservation solution, Neuraly and Arkivum identified and defined all of their requirements ensuring they were fully compliant with FDA regulations, GCP standards and in alignment with ALCOA+ principles.

If you’re interested in reading more about Neuraly’s digital preservation journey and how they became compliant with these regulations, please click here.

Ready to find out more?

Submit your details below for a personalised demo showing how your organisation could be benefitting from long-term data management today. Fields marked with an * are required. Need more information? See our blog or contact us.